BPS Bioscience
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BPS offers one of the largest selections of unique recombinant proteins and assay kits for epigenetic studies, immune checkpoints, metabolism and cell signaling pathways to improve human health.
Cloning and Expression: BPS Bioscience's Molecular Biology Services team can help you achieve any molecular biology research goal you are trying to achieve. Our gene cloning and site-directed mutagenesis services are often the first step in custom protein expression, analytic development, and custom cell line development projects.
Purification and Protein Modification: Choose BPS Bioscience for your protein, reduction, purification and modification needs. Using our cloning and expression services, the constructs can be optimized for high purity, high performance protein expression. We are also specialized in protein labeling to provide improved products for high quality testing.
Cell line development: Let our experts help you reduce time and complexity with our stable cell line development services. We produce customized cell lines for protein production and compound screening. Our specialty in reporter assays for immune control pathways offers great opportunities for research on co-immunotherapies.
Test Development and Screening Services: Evaluate key compounds with our biochemical and cell screening services. Save time by allowing us to filter your compounds of interest against our unique test panels or to determine IC50 values with our portfolio of hundreds of tests so you can focus on advancing your discovery program of drugs.
Learn more :
Watch the video :
Website: bpsbioscience.com
|
![Lung cancer](https://www.clinisciences.com/en/upload/16-zzrhwq.png)
Lung cancer
Lung cancer is a disease that develops in the cells of the lung. There are two main forms of lung cancer: non-small cell lung cancer (NSCLC), which accounts for almost 85% of cases, and small cell lung cancer (SCLC), which accounts for almost 15% of cases.
Lung cancer, a formidable disease, is one of the major challenges facing world health. Characterised by the abnormal growth of lung cells, this cancer encompasses a diversity of subtypes, contributing to its complexity and varied clinical implications. As cancer cells proliferate uncontrollably, they can invade neighbouring tissues and spread to other parts of the body via the lymphatic or blood systems. Lung cancer, as a pathological entity, represents a major medical challenge at the crossroads of cell biology, epidemiology and clinical medicine.
The different forms of lung cancer, such as small-cell bronchial carcinoma and non-small-cell bronchial carcinoma, bear witness to the genetic diversity underlying this disease. Genomic alterations, such as KRAS gene mutations or ALK gene rearrangements, are contributing to a growing understanding of the specific oncogenic mechanisms involved in disease initiation and progression.
The origin of lung cancer is often associated with genetic mutations triggered by environmental factors such as smoking, exposure to carcinogens or other complex variables. Scientific advances have led to a better understanding of the underlying biology of this disease, shedding light on the specific molecular mechanisms that contribute to its development.
Select the cells below to find the most commonly used cell lines complete for each specified cell type.
Search result : 4 product found
Refine your search :
- Cell line 4
- human 2
- Assay 1